An Overview of Progress in Myeloma Research with Dr. James Berenson
Myeloma news from the 2014 annual meeting of the American Society of Clinical Oncology has…
read moreASCO 2014: Results of the dose-escalation portion of a phase 1/2 study (CHAMPION-1) investigating weekly carfilzomib in combination with dexamethasone for patients with relapsed or refractory multiple myeloma
Abstract No: 8594 Background: Carfilzomib (CFZ) is a selective proteasome inhibitor approved in the US…
read moreTommy Garceau, IMBCR’s Marathon Team Captain
Tommy, who has been Dr. Berenson’s able assistant for many years, has a passion for…
read moreTalking About Myeloma with Loved Ones
Do you feel the Love? The New Year is here. Perhaps you have been newly…
read moreCounterpoints: Do Patients With Multiple Myeloma Need Maintenance Treatment?
By Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Multiple myeloma…
read moreKIIS Cares Interview
What: Myeloma is a disease in your bone marrow. Inside your bone marrow are the…
read moreIMBCR Identifies New Treatments for Myeloma in 2015!
First, we have made much progress on our new protein marker called B-cell maturation antigen…
read moreI Have WHAT? An Interview With Patient Advocate Debra Berenson
Interview with Debra Berenson, myeloma patient advocate, wife of myeloma expert Dr. James Berenson, and…
read moreTo Transplant or Not To Transplant in Multiple Myeloma
Clinical Advances in Hematology & Oncology [button style=”download” link=”https://www.hematologyandoncology.net/files/2014/05/ho0514_counter1.pdf” color=”teal”]Download Paper[/button] Authors: James R. Berenson,…
read moreAdvances in the Management of Multiple Myeloma
James R Berenson, MD,abc Tanya M Spektor, PhD,c and James Wang, MDab aInstitute for Myeloma…
read more